FDA Inspection 824712 — ImpactLife
The FDA completed an inspection of ImpactLife on Mar 26, 2013 in Moline, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 26, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Moline, IL (United States)